Clinical Trial News and Research

RSS

Research that directs cancer-killing immune cells against the deadliest brain tumors shows promise

Researchers seeking to direct cancer-killing immune cells against the deadliest brain tumors have three new targets that show promise in laboratory studies and in a Phase I patient trial, according to two articles in the July 15 issue of the journal Cancer Research.

15 Jul 2004

Strategic analysis of the breast cancer therapeutics pipeline

Strategic partnerships between the pharmaceuticals industry and the biotechnology sector are making breast cancer therapeutics one of the most dynamic segments in the overall oncology market.

15 Jul 2004

Study evaluates effectiveness of LEXIVA/ritonavir and Lopinavir/ritonavir in protease inhibitor

HIV treatment regimens containing the protease inhibitor (PI) LEXIVA® (fosamprenavir calcium) dosed with ritonavir (LEXIVA/r) or lopinavir (LPV) and ritonavir (LPV/r) were effective in suppressing HIV in patients who had failed prior PI-containing regimens, according to information presented at the International AIDS Conference (IAC).

12 Jul 2004

Cheap AIDS drugs may help prevent HIV in babies in Thailand

Aids is one of the principal causes of infant mortality in many developing countries. Viral transmission takes place during pregnancy (in utero), at the moment of childbirth or even during breastfeeding.

10 Jul 2004

Evidence that new anti-inflammatory drug may sensitize leukemia, and breast and lung cancers to conventional chemotherapy

Ohio researchers have used a recently developed anti-inflammatory drug as a starting point to construct a possible new, targeted anti-cancer agent.

10 Jul 2004

Myriad Genetics awarded a $14.2 million contract for AIDS and hepatitis research

Myriad Genetics has announced that it has been awarded a five-year, $14.2 million contract by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

10 Jul 2004

Chemoradioimmunotherapy for advanced breast cancer

A successful, and novel, technique to kill metastatic breast cancer cells by circumventing their chemo- and radioresistant mechanisms was by presented by Dr John Giannios, Head of Radiotherapeutic Cancer Research at the IASO Hospital

8 Jul 2004

Endo announces agreement With FDA for new trial design of oxymorphone extended-release tablets

Endo Pharmaceuticals Inc., a wholly owned subsidiary of Endo Pharmaceuticals Holdings Inc., today announced that it has reached agreement with the U.S. Food and Drug Administration

7 Jul 2004

Combining targeted immunotherapy with chemotherapy and radiation therapy to successfully kill metastatic tumour cells

A successful, and novel, technique to kill metastatic breast cancer cells by circumventing their chemo and radioresistant mechanisms was by presented by Dr. John Giannios, Head of Radiotherapeutic Cancer Research at the IASO Hospital

7 Jul 2004

Inexpensive generic fixed-dose combined therapies appears the most suitable solution for treating AIDS in developing countries

The development of simple and inexpensive generic fixed-dose combined therapies appears the most suitable solution for making possible this access to treatments in developing countries with meagre resources.

3 Jul 2004

Drop in systolic blood pressure may indicate imminent likelihood of Alzheimer’s disease or dementia

Journal of the American Heart Association reports that a significant drop in systolic blood pressure may indicate imminent likelihood of Alzheimer’s disease or dementia in some elderly people.

2 Jul 2004

Generic fixed-dose combinations (FDCs) of antiretrovirals are a key factor in access to treatment of HIV/AIDS infection in the developing world

Combination therapy with three generic antiretroviral drugs in a single tablet has been validated for the first time in an open clinical study in a developing country. Follow-up of 60 patients treated in Yaoundé, Cameroon, has demonstrated the excellent efficacy and safety of a generic fixed-dose combination.

2 Jul 2004

Access to HIV antiretroviral therapies in the developing world should be a major world health priority

One of the strategies adopted consists in utilizing combinations of fixed doses of generic antiretrovirals, involving three medicinal drugs of two different classes in the same tablet.

2 Jul 2004

Physical activity cuts risk of depression in children

Students who increase their physical activity during their middle-school years have fewer symptoms of depression, according to a new study.

1 Jul 2004

Aspartame in foods and beverages can help with weight loss and long-term control of body weight

Contrary to the hypothesis of two Purdue University researchers just published in the International Journal of Obesity, several studies have shown that the use of aspartame in foods and beverages can help with weight loss and long-term control of body weight and does not increase hunger or food intake in children or adults.

30 Jun 2004

Clinical Trial News and Research

Research that directs cancer-killing immune cells against the deadliest brain tumors shows promise

Strategic analysis of the breast cancer therapeutics pipeline

Study evaluates effectiveness of LEXIVA/ritonavir and Lopinavir/ritonavir in protease inhibitor

Cheap AIDS drugs may help prevent HIV in babies in Thailand

Evidence that new anti-inflammatory drug may sensitize leukemia, and breast and lung cancers to conventional chemotherapy

Myriad Genetics awarded a $14.2 million contract for AIDS and hepatitis research

Chemoradioimmunotherapy for advanced breast cancer

Endo announces agreement With FDA for new trial design of oxymorphone extended-release tablets

Combining targeted immunotherapy with chemotherapy and radiation therapy to successfully kill metastatic tumour cells

Inexpensive generic fixed-dose combined therapies appears the most suitable solution for treating AIDS in developing countries

Drop in systolic blood pressure may indicate imminent likelihood of Alzheimer’s disease or dementia

Generic fixed-dose combinations (FDCs) of antiretrovirals are a key factor in access to treatment of HIV/AIDS infection in the developing world

Access to HIV antiretroviral therapies in the developing world should be a major world health priority

Physical activity cuts risk of depression in children

Aspartame in foods and beverages can help with weight loss and long-term control of body weight

Alcon updates filing status of RETAANE® new drug application

About 40 percent of U.S. adults ages 40 to 74 — millions of whom are Hispanic or Latino — currently have pre-diabetes

Immune modulation therapy, latest treatment for people with chronic heart failure

Exelixis files new drug application for a proprietary novel anticancer compound

Alzheimer’s Society expresses concern over new study on dementia drug effectiveness, published in The Lancet

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest Life Science News